353 related articles for article (PubMed ID: 7569729)
21. Atrial natriuretic factor, cyclic 3',5'-guanosine monophosphate and prostaglandin E2 in liver cirrhosis: relation to blood volume and changes in blood volume after furosemide.
Jespersen B; Jensen L; Sørensen SS; Pedersen EB
Eur J Clin Invest; 1990 Dec; 20(6):632-41. PubMed ID: 1964125
[TBL] [Abstract][Full Text] [Related]
22. Atrial natriuretic peptide in preeclampsia: metabolic clearance, sodium excretion and renal hemodynamics.
Irons DW; Baylis PH; Butler TJ; Davison JM
Am J Physiol; 1997 Sep; 273(3 Pt 2):F483-7. PubMed ID: 9321923
[TBL] [Abstract][Full Text] [Related]
23. Muscle sympathetic nerve activity and renal responsiveness to atrial natriuretic factor during the development of hepatic ascites.
Morali GA; Floras JS; Legault L; Tobe S; Skorecki KL; Blendis LM
Am J Med; 1991 Oct; 91(4):383-92. PubMed ID: 1835288
[TBL] [Abstract][Full Text] [Related]
24. Effects of repeated atrial natriuretic peptide bolus injections in cirrhotic patients with refractory ascites.
Laffi G; Marra F; Pinzani M; Meacci E; Tosti-Guerra C; De Feo ML; Gentilini P
Liver; 1989 Dec; 9(6):315-21. PubMed ID: 2532698
[TBL] [Abstract][Full Text] [Related]
25. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans.
Eiskjaer H; Nielsen CB; Pedersen EB
J Hypertens; 1996 Jan; 14(1):99-106. PubMed ID: 12013501
[TBL] [Abstract][Full Text] [Related]
26. Reversal of atrial natriuretic peptide resistance by increasing distal tubular sodium delivery in patients with decompensated cirrhosis.
Abraham WT; Lauwaars ME; Kim JK; Peña RL; Schrier RW
Hepatology; 1995 Sep; 22(3):737-43. PubMed ID: 7657277
[TBL] [Abstract][Full Text] [Related]
27. Effect of pinacidil on renal haemodynamics, tubular function and plasma levels of angiotensin II, aldosterone and atrial natriuretic peptide in healthy man.
Nielsen CB; Pedersen EB
Eur J Clin Pharmacol; 1993; 45(1):29-35. PubMed ID: 8405026
[TBL] [Abstract][Full Text] [Related]
28. Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation.
Wong F; Tobe S; Legault L; Logan AG; Skorecki K; Blendis LM
Hepatology; 1993 Sep; 18(3):519-28. PubMed ID: 8395457
[TBL] [Abstract][Full Text] [Related]
29. Atrial natriuretic peptide increases albuminuria in type I diabetic patients: evidence for blockade of tubular protein reabsorption.
Jacobs EM; Vervoort G; Branten AJ; Klasen I; Smits P; Wetzels JF
Eur J Clin Invest; 1999 Feb; 29(2):109-15. PubMed ID: 10092997
[TBL] [Abstract][Full Text] [Related]
30. Effect of frusemide on atrial natriuretic peptide, guanosine cyclic monophosphate, angiotensin II, aldosterone, vasopressin, prostaglandin E2 and blood volume in the nephrotic syndrome.
Jespersen B; Sørensen SS; Pedersen EB
Nephrol Dial Transplant; 1991; 6(6):402-9. PubMed ID: 1652115
[TBL] [Abstract][Full Text] [Related]
31. Effects of captopril on renal function in healthy uninephrectomized subjects and in healthy control subjects.
Nielsen CB; Pedersen EB
J Intern Med; 1994 Apr; 235(4):359-65. PubMed ID: 8151269
[TBL] [Abstract][Full Text] [Related]
32. Renal interaction of atrial natriuretic peptide with angiotensin II: glomerular and tubular effects.
Rakugi H; Ogihara T; Nakamaru M; Saito H; Shima J; Sakaguchi K; Kumahara Y
Clin Exp Pharmacol Physiol; 1989 Feb; 16(2):97-107. PubMed ID: 2523767
[TBL] [Abstract][Full Text] [Related]
33. Role of altered systemic hemodynamics in the blunted renal response to atrial natriuretic peptide in rats with cirrhosis and ascites.
López C; Jiménez W; Arroyo V; La Villa G; Gaya J; Clària J; Rivera F; Rodés J
J Hepatol; 1989 Sep; 9(2):217-26. PubMed ID: 2530268
[TBL] [Abstract][Full Text] [Related]
34. Regulation of glomerular filtration in essential hypertension: role of abnormal Na+ transport and atrial natriuretic peptide.
Semplicini A; Ceolotto G; Sartori M; Maresca A; Baritono E; De Toni R; Paparella I; Calò L
J Nephrol; 2002; 15(5):489-96. PubMed ID: 12455714
[TBL] [Abstract][Full Text] [Related]
35. Role of endogenous atrial natriuretic peptide in chronic anemia in the ovine fetus: effects of a non-peptide antagonist for atrial natriuretic peptide receptor.
Silberbach M; Woods LL; Hohimer AR; Shiota T; Matsuda Y; Davis LE
Pediatr Res; 1995 Nov; 38(5):722-8. PubMed ID: 8552440
[TBL] [Abstract][Full Text] [Related]
36. Effect of potassium supplementation on renal tubular function, ambulatory blood pressure and pulse wave velocity in healthy humans.
Matthesen SK; Larsen T; Vase H; Lauridsen TG; Pedersen EB
Scand J Clin Lab Invest; 2012 Feb; 72(1):78-86. PubMed ID: 22149452
[TBL] [Abstract][Full Text] [Related]
37. Abnormal tubular handling of sodium and water induced by atrial natriuretic peptide in essential hypertension.
Eiskjaer H; Jensen JD; Jespersen B; Sørensen SS; Pedersen EB
J Intern Med; 1991 Jul; 230(1):37-48. PubMed ID: 1829753
[TBL] [Abstract][Full Text] [Related]
38. Enhanced external counterpulsation: a new technique to augment renal function in liver cirrhosis.
Werner D; Trägner P; Wawer A; Porst H; Daniel WG; Gross P
Nephrol Dial Transplant; 2005 May; 20(5):920-6. PubMed ID: 15788437
[TBL] [Abstract][Full Text] [Related]
39. Natriuretic response to the combination of atrial natriuretic peptide and terlipressin in patients with cirrhosis and refractory ascites.
Gadano A; Moreau R; Vachiery F; Soupison T; Yang S; Cailmail S; Sogni P; Hadengue A; Durand F; Valla D; Lebrec D
J Hepatol; 1997 Jun; 26(6):1229-34. PubMed ID: 9210608
[TBL] [Abstract][Full Text] [Related]
40. Intranasal application of atrial natriuretic peptide and 1-deamino-d-arginine vasopressin in healthy volunteers. Hemodynamic, hormonal, and renal excretory effects.
Predel HG; Kuklinski P; Kramer HJ
Am J Hypertens; 1992 Sep; 5(9):657-60. PubMed ID: 1329853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]